JULIE GASTIER-FOSTER to Neoadjuvant Therapy
This is a "connection" page, showing publications JULIE GASTIER-FOSTER has written about Neoadjuvant Therapy.
Connection Strength
0.178
-
Maintaining Outstanding Outcomes Using Response- and Biology-Based Therapy for Intermediate-Risk Neuroblastoma: A Report From the Children's Oncology Group Study ANBL0531. J Clin Oncol. 2019 12 01; 37(34):3243-3255.
Score: 0.144
-
No evidence that G6PD deficiency affects the efficacy or safety of daunorubicin in acute lymphoblastic leukemia induction therapy. Pediatr Blood Cancer. 2019 06; 66(6):e27681.
Score: 0.035